Macrophage Pharma

Macrophage Pharma is an immuno-oncology company focussed on the discovery and development of novel therapies designed to enhance anti-tumour immune responses.
Macrophage Pharma’s technology platform is designed to deliver small molecule drugs to tumour associated macrophages in a highly selective manner to activate the body’s natural immune system to fight cancer.

Team Members
more about
Alicia Irurzun-Lafitte
more about
Hakan Goker
more about
Cheryl Zimberlin
Latest News Entry
Macrophage Pharma Appoints Dr Michael Moore as Chairman

Macrophage Pharma Limited (‘MPL’) announced today that it has appointed Dr. Michael Moore as non-executive Chairman with immediate effect.

Macrophage Pharma Limited Extends Series A Round to Include New Investor Merck Ventures

Merck Ventures Joins Investment Syndicate and the Board of Macrophage

all portfolio news